{"id":1010,"date":"2026-07-08T09:11:28","date_gmt":"2026-07-08T09:11:28","guid":{"rendered":"https:\/\/opture.com\/?page_id=1010"},"modified":"2026-09-10T22:35:53","modified_gmt":"2026-09-10T22:35:53","slug":"pharmaindustrie","status":"publish","type":"page","link":"https:\/\/opture.com\/fr\/branchen\/pharmaindustrie\/","title":{"rendered":"industrie pharmaceutique"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1010\" class=\"elementor elementor-1010\" data-elementor-settings=\"{&quot;element_pack_global_tooltip_width&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_width_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;element_pack_global_tooltip_padding&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_padding_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;element_pack_global_tooltip_border_radius_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true}}\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-843430b e-flex e-con-boxed e-con e-parent\" data-id=\"843430b\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-f671b41 e-con-full e-flex e-con e-child\" data-id=\"f671b41\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-feca893 elementor-widget elementor-widget-breadcrumbs\" data-id=\"feca893\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"breadcrumbs.default\">\n\t\t\t\t\t<p id=\"breadcrumbs\"><span><span><a href=\"https:\/\/opture.com\/\">Home<\/a><\/span><\/span><\/p>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-86cc30c elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"86cc30c\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInUp&quot;,&quot;_animation_delay&quot;:240}\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Regulatorisches Risiko- und Compliance-Management f\u00fcr die Pharmaindustrie<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-72c9d1c elementor-widget-tablet__width-inherit elementor-invisible elementor-widget elementor-widget-text-editor\" data-id=\"72c9d1c\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInUp&quot;,&quot;_animation_delay&quot;:320}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5c8e24f ui-e-align-left elementor-widget__width-initial ui-e-align-tablet-left ui-e-align-mobile-left ui-e-top elementor-widget elementor-widget-uicore-icon-box\" data-id=\"5c8e24f\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;position&quot;:&quot;top&quot;,&quot;content_padding&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true}}\" data-widget_type=\"uicore-icon-box.default\"><div class=\"ui-e-ico-box\"><div class=\"ui-e-box-content\"><div class=\"ui-e-description\"><p data-path-to-node=\"4\">Mit der integrierten <a href=\"https:\/\/opture.com\/loesungen\/regulatory-operating-system\/\">OPTURE RegOS<\/a> Plattform steuern Pharmaunternehmen regulatorische Anforderungen, GMP-Qualit\u00e4tsprozesse, globale Lieferketten, komplexe Forschung &amp; Entwicklung (F&amp;E) sowie digitale Risiken in einer einzigen, revisionssicheren Umgebung.<\/p><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5048394 elementor-invisible elementor-widget elementor-widget-button\" data-id=\"5048394\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInUp&quot;,&quot;_animation_delay&quot;:400}\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/opture.com\/contact-us\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\"> Kontaktieren Sie uns<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f1bdbd6 e-flex e-con-boxed e-con e-parent\" data-id=\"f1bdbd6\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-79b1065 e-con-full e-flex e-con e-child\" data-id=\"79b1065\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f52198d elementor-widget elementor-widget-heading\" data-id=\"f52198d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">QUALIT\u00c4T UND COMPLIANCE F\u00dcR PHARMA &amp; BIOTECH<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-28cfb8c elementor-widget elementor-widget-heading\" data-id=\"28cfb8c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Sicherheit f\u00fcr regulierte Pharma-Prozesse<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-33bec00 elementor-widget__width-initial elementor-widget-mobile__width-inherit elementor-widget-tablet__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"33bec00\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p data-path-to-node=\"10\"><span data-path-to-node=\"8,0\">Wie Pharma- und Biotech-Unternehmen regulatorische Anforderungen, GMP-Qualit\u00e4tsprozesse, F&amp;E-Risiken und Compliance-Pflichten mit integrierter Plattformtechnologie transparent und resilient steuern<\/span><span data-path-to-node=\"8,2\">.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5d09e39 ui-e-align-left ui-e-align-tablet-left ui-e-left ui-e-align-mobile-left elementor-widget__width-initial elementor-widget-tablet__width-inherit elementor-widget elementor-widget-uicore-icon-box\" data-id=\"5d09e39\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;position&quot;:&quot;left&quot;,&quot;content_padding&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true}}\" data-widget_type=\"uicore-icon-box.default\">\n\t\t\t\t\t\n        <div class=\"ui-e-ico-box\" >\n\n            \n            <div class='ui-e-flex-wrp'>\n\n                                    <div class=\"ui-e-icon-wrp\">\n\n                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-shield-alt\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M466.5 83.7l-192-80a48.15 48.15 0 0 0-36.9 0l-192 80C27.7 91.1 16 108.6 16 128c0 198.5 114.5 335.7 221.5 380.3 11.8 4.9 25.1 4.9 36.9 0C360.1 472.6 496 349.3 496 128c0-19.4-11.7-36.9-29.5-44.3zM256.1 446.3l-.1-381 175.9 73.3c-3.3 151.4-82.1 261.1-175.8 307.7z\"><\/path><\/svg>\n                    <\/div>\n                \n                \n            <\/div>\n\n            <div class=\"ui-e-box-content\">\n                <div class=\"ui-e-title-wrp\"><h5 class=\"ui-e-title\">Globale Regulatorik &amp; GMP<\/h5><\/div>\n                <div class=\"ui-e-description\">\n                    <p data-path-to-node=\"11,0,0\"><span data-path-to-node=\"11,1,0,0\">Richtlinien wie GMP, FDA und EMA sowie Validierungspflichten pr\u00e4gen die Branche<\/span><span data-path-to-node=\"11,1,0,2\">. Diese extreme regulatorische Dichte erfordert zentrale, revisionssichere Governance-Strukturen<\/span><span data-path-to-node=\"11,1,0,4\">.<\/span><\/p>                <\/div>\n\n                \n            <\/div>\n        <\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6cac567 ui-e-align-left ui-e-align-tablet-left ui-e-left ui-e-align-mobile-left elementor-widget__width-initial elementor-widget-tablet__width-inherit elementor-widget elementor-widget-uicore-icon-box\" data-id=\"6cac567\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;position&quot;:&quot;left&quot;,&quot;content_padding&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true}}\" data-widget_type=\"uicore-icon-box.default\">\n\t\t\t\t\t\n        <div class=\"ui-e-ico-box\" >\n\n            \n            <div class='ui-e-flex-wrp'>\n\n                                    <div class=\"ui-e-icon-wrp\">\n\n                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-cog\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M487.4 315.7l-42.6-24.6c4.3-23.2 4.3-47 0-70.2l42.6-24.6c4.9-2.8 7.1-8.6 5.5-14-11.1-35.6-30-67.8-54.7-94.6-3.8-4.1-10-5.1-14.8-2.3L380.8 110c-17.9-15.4-38.5-27.3-60.8-35.1V25.8c0-5.6-3.9-10.5-9.4-11.7-36.7-8.2-74.3-7.8-109.2 0-5.5 1.2-9.4 6.1-9.4 11.7V75c-22.2 7.9-42.8 19.8-60.8 35.1L88.7 85.5c-4.9-2.8-11-1.9-14.8 2.3-24.7 26.7-43.6 58.9-54.7 94.6-1.7 5.4.6 11.2 5.5 14L67.3 221c-4.3 23.2-4.3 47 0 70.2l-42.6 24.6c-4.9 2.8-7.1 8.6-5.5 14 11.1 35.6 30 67.8 54.7 94.6 3.8 4.1 10 5.1 14.8 2.3l42.6-24.6c17.9 15.4 38.5 27.3 60.8 35.1v49.2c0 5.6 3.9 10.5 9.4 11.7 36.7 8.2 74.3 7.8 109.2 0 5.5-1.2 9.4-6.1 9.4-11.7v-49.2c22.2-7.9 42.8-19.8 60.8-35.1l42.6 24.6c4.9 2.8 11 1.9 14.8-2.3 24.7-26.7 43.6-58.9 54.7-94.6 1.5-5.5-.7-11.3-5.6-14.1zM256 336c-44.1 0-80-35.9-80-80s35.9-80 80-80 80 35.9 80 80-35.9 80-80 80z\"><\/path><\/svg>\n                    <\/div>\n                \n                \n            <\/div>\n\n            <div class=\"ui-e-box-content\">\n                <div class=\"ui-e-title-wrp\"><h5 class=\"ui-e-title\">F&amp;E- und Zulassungsrisiken<\/h5><\/div>\n                <div class=\"ui-e-description\">\n                    <p data-path-to-node=\"11,1,0\"><span data-path-to-node=\"13,1,0,0\"> Klinische Studien, lange Entwicklungszyklen und Zulassungsverfahren bergen hohe Investitionsrisiken<\/span><span data-path-to-node=\"13,1,0,2\">. Fehlende Transparenz f\u00fchrt hier schnell zu erheblichen wirtschaftlichen Einbu\u00dfen<\/span><span data-path-to-node=\"13,1,0,4\">.<\/span><\/p>                <\/div>\n\n                \n            <\/div>\n        <\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9bf4291 ui-e-align-left ui-e-align-tablet-left ui-e-left ui-e-align-mobile-left elementor-widget__width-initial elementor-widget-tablet__width-inherit elementor-widget elementor-widget-uicore-icon-box\" data-id=\"9bf4291\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;position&quot;:&quot;left&quot;,&quot;content_padding&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true},&quot;content_padding_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;top&quot;:&quot;&quot;,&quot;right&quot;:&quot;&quot;,&quot;bottom&quot;:&quot;&quot;,&quot;left&quot;:&quot;&quot;,&quot;isLinked&quot;:true}}\" data-widget_type=\"uicore-icon-box.default\">\n\t\t\t\t\t\n        <div class=\"ui-e-ico-box\" >\n\n            \n            <div class='ui-e-flex-wrp'>\n\n                                    <div class=\"ui-e-icon-wrp\">\n\n                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-key\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M512 176.001C512 273.203 433.202 352 336 352c-11.22 0-22.19-1.062-32.827-3.069l-24.012 27.014A23.999 23.999 0 0 1 261.223 384H224v40c0 13.255-10.745 24-24 24h-40v40c0 13.255-10.745 24-24 24H24c-13.255 0-24-10.745-24-24v-78.059c0-6.365 2.529-12.47 7.029-16.971l161.802-161.802C163.108 213.814 160 195.271 160 176 160 78.798 238.797.001 335.999 0 433.488-.001 512 78.511 512 176.001zM336 128c0 26.51 21.49 48 48 48s48-21.49 48-48-21.49-48-48-48-48 21.49-48 48z\"><\/path><\/svg>\n                    <\/div>\n                \n                \n            <\/div>\n\n            <div class=\"ui-e-box-content\">\n                <div class=\"ui-e-title-wrp\"><h5 class=\"ui-e-title\">Lieferketten &amp; API-Abh\u00e4ngigkeiten<\/h5><\/div>\n                <div class=\"ui-e-description\">\n                    <p data-path-to-node=\"11,2,0\"><span data-path-to-node=\"15,1,0,0\">Wirkstoffe (APIs) und Rohstoffe stammen aus globalen Netzwerken<\/span><span data-path-to-node=\"15,1,0,2\">. Engp\u00e4sse und Preisvolatilit\u00e4t wirken sich direkt auf Produktion und Versorgungssicherheit aus<\/span><span data-path-to-node=\"15,1,0,4\">.<\/span><\/p>                <\/div>\n\n                \n            <\/div>\n        <\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b49a8ef e-con-full e-flex e-con e-child\" data-id=\"b49a8ef\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b0a7d53 elementor-widget elementor-widget-heading\" data-id=\"b0a7d53\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Branchenprofil &amp; regulatorische Ausgangslage<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fd48efe elementor-widget__width-initial elementor-widget-mobile__width-inherit elementor-widget-tablet__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"fd48efe\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Die Pharmaindustrie wird von strengsten weltweiten Vorgaben wie GMP, GXP, FDA, EMA und der AMWHV dominiert. Gleichzeitig steigen die beh\u00f6rdlichen Anforderungen an die l\u00fcckenlose Dokumentation,<\/span> <span style=\"font-weight: 400;\">Pharmakovigilanz (Arzneimittelsicherheit &#8211; die systematische Erfassung, Bewertung und \u00dcberwachung von Arzneimitteln, um unerw\u00fcnschte Nebenwirkungen fr\u00fchzeitig zu erkennen) und Auditf\u00e4higkeit in F&amp;E- und Produktionsprozessen rasant an.<\/span><\/p><p id=\"p-rc_413bc4c33fab9973-83\" data-path-to-node=\"4\"><span data-path-to-node=\"4,0\">Nur wer durchg\u00e4ngige Transparenz \u00fcber alle Datenschnittstellen schafft, kann diese komplexen Validierungspflichten und Compliance-H\u00fcrden zukunftssicher bew\u00e4ltigen<\/span><span data-path-to-node=\"4,2\">.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e25949e inhalt e-flex e-con-boxed e-con e-parent\" data-id=\"e25949e\" data-element_type=\"container\" data-e-type=\"container\" id=\"inhalt\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2cb4fb9 e-con-full e-flex e-con e-child\" data-id=\"2cb4fb9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-d80d8cd e-con-full e-flex e-con e-child\" data-id=\"d80d8cd\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;sticky&quot;:&quot;top&quot;,&quot;sticky_offset&quot;:100,&quot;sticky_parent&quot;:&quot;yes&quot;,&quot;sticky_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;,&quot;mobile&quot;],&quot;sticky_effects_offset&quot;:0,&quot;sticky_anchor_link_offset&quot;:0}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-35f76eb elementor-toc--minimized-on-tablet elementor-widget elementor-widget-table-of-contents\" data-id=\"35f76eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;container&quot;:&quot;#inhalt&quot;,&quot;exclude_headings_by_selector&quot;:[],&quot;marker_view&quot;:&quot;bullets&quot;,&quot;icon&quot;:{&quot;value&quot;:&quot;&quot;,&quot;library&quot;:&quot;&quot;},&quot;no_headings_message&quot;:&quot;Keine Inhalte gefunden.&quot;,&quot;min_height&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:0,&quot;sizes&quot;:[]},&quot;headings_by_tags&quot;:[&quot;h2&quot;],&quot;minimize_box&quot;:&quot;yes&quot;,&quot;minimized_on&quot;:&quot;tablet&quot;,&quot;hierarchical_view&quot;:&quot;yes&quot;,&quot;min_height_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;min_height_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"table-of-contents.default\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-toc__header\">\n\t\t\t\t\t\t<h4 class=\"elementor-toc__header-title\">\n\t\t\t\tInhalt\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-toc__toggle-button elementor-toc__toggle-button--expand\" role=\"button\" tabindex=\"0\" aria-controls=\"elementor-toc__35f76eb\" aria-expanded=\"true\" aria-label=\"Inhaltsverzeichnis \u00f6ffnen\"><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-down\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M207.029 381.476L12.686 187.132c-9.373-9.373-9.373-24.569 0-33.941l22.667-22.667c9.357-9.357 24.522-9.375 33.901-.04L224 284.505l154.745-154.021c9.379-9.335 24.544-9.317 33.901.04l22.667 22.667c9.373 9.373 9.373 24.569 0 33.941L240.971 381.476c-9.373 9.372-24.569 9.372-33.942 0z\"><\/path><\/svg><\/div>\n\t\t\t\t<div class=\"elementor-toc__toggle-button elementor-toc__toggle-button--collapse\" role=\"button\" tabindex=\"0\" aria-controls=\"elementor-toc__35f76eb\" aria-expanded=\"true\" aria-label=\"Inhaltsverzeichnis schlie\u00dfen\"><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-chevron-up\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M240.971 130.524l194.343 194.343c9.373 9.373 9.373 24.569 0 33.941l-22.667 22.667c-9.357 9.357-24.522 9.375-33.901.04L224 227.495 69.255 381.516c-9.379 9.335-24.544 9.317-33.901-.04l-22.667-22.667c-9.373-9.373-9.373-24.569 0-33.941L207.03 130.525c9.372-9.373 24.568-9.373 33.941-.001z\"><\/path><\/svg><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<div id=\"elementor-toc__35f76eb\" class=\"elementor-toc__body\">\n\t\t\t<div class=\"elementor-toc__spinner-container\">\n\t\t\t\t<svg class=\"elementor-toc__spinner eicon-animation-spin e-font-icon-svg e-eicon-loading\" aria-hidden=\"true\" viewBox=\"0 0 1000 1000\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M500 975V858C696 858 858 696 858 500S696 142 500 142 142 304 142 500H25C25 237 238 25 500 25S975 237 975 500 763 975 500 975Z\"><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5e82450 e-con-full e-flex e-con e-child\" data-id=\"5e82450\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-46a385a elementor-widget__width-initial elementor-widget-mobile__width-inherit elementor-widget-tablet__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"46a385a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 data-path-to-node=\"1\">Vollst\u00e4ndige Transparenz: So meistern Pharmaunternehmen die Risiko-Transformation<\/h2><h3 data-path-to-node=\"3\">Komplexe F&amp;E-Zyklen treffen auf volatile Lieferketten<\/h3><p id=\"p-rc_5dc725f52b2e4c1f-92\" data-path-to-node=\"4\"><span data-path-to-node=\"4,0\">Die Pharmabranche durchlebt eine Phase massiven Margen- und Innovationsdrucks<\/span><span data-path-to-node=\"4,2\">. Unw\u00e4gbarkeiten in klinischen Studien und hochvolatile API-Lieferketten gef\u00e4hrden die Time-to-Market erheblich<\/span><span data-path-to-node=\"4,4\">. Um komplexe Zulassungs- und Produktionsrisiken proaktiv zu mitigieren, sto\u00dfen klassische Insell\u00f6sungen an ihre Grenzen<\/span><span data-path-to-node=\"4,6\">. Zwingend gefordert ist heute ein ganzheitliches, integriertes Enterprise Risk Management (ERM)<\/span><span data-path-to-node=\"4,8\">.<\/span><\/p><h3 data-path-to-node=\"2\">Der regulatorische Tsunami: GMP-Richtlinien, FDA-Audits und Validierungspflichten<\/h3><p id=\"p-rc_529a9fc4a93bb7a2-125\" data-path-to-node=\"3\"><span data-path-to-node=\"3,0\">Eine beispiellose Regulierungswelle erfasst derzeit die gesamte Pharmabranche<\/span><span data-path-to-node=\"3,2\">. Strengste internationale Standards wie GMP, GXP, FDA- und EMA-Vorgaben sowie die AMWHV zwingen forschende und produzierende Unternehmen zu radikaler digitaler Transparenz<\/span><span data-path-to-node=\"3,4\">. Diese massiven Compliance-Anforderungen durchdringen mittlerweile die komplette Wertsch\u00f6pfungskette \u2013 angefangen bei klinischen Studien \u00fcber die Auditierung globaler API-Lieferanten bis hin zur endg\u00fcltigen Marktzulassung<\/span><span data-path-to-node=\"3,6\">.<\/span><\/p><blockquote data-path-to-node=\"6\"><p data-path-to-node=\"6,0\">\u201eWer komplexe Validierungspflichten und Qualit\u00e4tsrisiken heute noch manuell in dezentralen Excel-Listen verwaltet, riskiert nicht nur gescheiterte Audits, sondern beh\u00f6rdliche Produktionsstopps und den sofortigen Entzug kritischer Zulassungen.\u201c<\/p><\/blockquote><h3 data-path-to-node=\"7\">Gefahr durch Datensilos: Warum Insell\u00f6sungen in der Pharma-Governance scheitern<\/h3><p data-path-to-node=\"8\"><span data-path-to-node=\"3,0\">Dezentrale Software-Silos gef\u00e4hrden die unternehmensweite Risikosteuerung<\/span><span data-path-to-node=\"3,2\">. Wenn F&amp;E-Teams ihre klinischen Studien, das Qualit\u00e4tsmanagement seine GMP-Validierungen und der Einkauf globale API-Lieferketten in isolierten Systemen verwalten, scheitert jede valide Risikoaggregation<\/span><span data-path-to-node=\"3,4\">. Strategische Entscheidungen geraten so zum Blindflug. <strong>OPTURE <a href=\"https:\/\/opture.com\/loesungen\/regulatory-operating-system\/\">RegOS<\/a><\/strong> vernetzt diesen gef\u00e4hrlichen Flickenteppich zu einer revisionssicheren <b data-path-to-node=\"3,4\" data-index-in-node=\"140\">Single Source of Truth<\/b><\/span><span data-path-to-node=\"3,6\">.<\/span><\/p><h2 data-path-to-node=\"4\">Die 10 Top-Risiken der Pharmaindustrie (und wie Sie diese beherrschen)<\/h2><h3 data-path-to-node=\"5\">F&amp;E-Risiken: Klinische Studien, Zyklen und Budgets pr\u00e4zise steuern<\/h3><p id=\"p-rc_83db03ae62a040f8-46\" data-path-to-node=\"6\"><span data-path-to-node=\"6,0\">Pharmazeutische Entwicklungsprozesse sind von extremer Volatilit\u00e4t gepr\u00e4gt<\/span><span data-path-to-node=\"6,2\">. Gefahren wie scheiternde klinische Studien, verz\u00f6gerte Zulassungsverfahren und ausufernde Forschungsbudgets bedrohen die Time-to-Market massiv<\/span><span data-path-to-node=\"6,4\">. Mit der <b data-path-to-node=\"6,4\" data-index-in-node=\"10\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/risikomanagement\/\">ERM<\/a> Software<\/b> bewerten Sie diese Unsicherheiten nicht nur qualitativ, sondern quantifizieren sie durch stochastische Simulationen mathematisch exakt<\/span><span data-path-to-node=\"6,6\">. Das Management \u00fcberblickt in Echtzeit die realen Erfolgswahrscheinlichkeiten und kann das Projektportfolio datengest\u00fctzt absichern<\/span><span data-path-to-node=\"6,8\">.<\/span><\/p><h3 data-path-to-node=\"2\">Lieferketten-Volatilit\u00e4t: APIs und Rohstoffe als Flaschenhals<\/h3><p id=\"p-rc_8884d26d0fedf2db-89\" data-path-to-node=\"3\"><span data-path-to-node=\"3,0\">Fluktuierende <b data-path-to-node=\"3,0\" data-index-in-node=\"14\">(4) Preisschwankungen bei Material und Energie<\/b> sowie das <b data-path-to-node=\"3,0\" data-index-in-node=\"71\">(5) Ausfallrisiko kritischer Wirkstofflieferanten (APIs)<\/b> gef\u00e4hrden die pharmazeutische Produktion<\/span><span data-path-to-node=\"3,2\">. Mit dem <b data-path-to-node=\"3,2\" data-index-in-node=\"10\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/internes-kontroll-system-iks\/\">IKS<\/a><\/b> \u00fcberwachen Unternehmen den Einkauf und das Lieferantennetzwerk l\u00fcckenlos<\/span><span data-path-to-node=\"3,4\">. Risiken werden direkt mit den Produktionsabl\u00e4ufen verkn\u00fcpft, um alternative Beschaffungswege rechtzeitig einzuleiten<\/span><span data-path-to-node=\"3,6\">.<\/span><\/p><h3 data-path-to-node=\"5\">Umwelt-, Nachhaltigkeits- und Reputationsrisiken<\/h3><p id=\"p-rc_8884d26d0fedf2db-90\" data-path-to-node=\"6\"><span data-path-to-node=\"6,0\">Pharmazeutische Prozesse bergen signifikante <b data-path-to-node=\"6,0\" data-index-in-node=\"45\">(6) Umwelt- und Nachhaltigkeitsrisiken (ESG)<\/b>, die eng mit <b data-path-to-node=\"6,0\" data-index-in-node=\"103\">(7) regulatorischen Risiken<\/b> und akuten <b data-path-to-node=\"6,0\" data-index-in-node=\"142\">(8) Reputationsrisiken<\/b> bei Qualit\u00e4tsm\u00e4ngeln verkn\u00fcpft sind<\/span><span data-path-to-node=\"6,2\">. \u00dcber <b data-path-to-node=\"6,2\" data-index-in-node=\"7\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/compliance-com\/\">COM<\/a><\/b> steuern Unternehmen ihre ESG-Compliance zentral<\/span><span data-path-to-node=\"6,4\">. Das integrierte <b data-path-to-node=\"6,4\" data-index-in-node=\"18\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/hgs-hinweisgebersystem\/\">HGS<\/a><\/b> garantiert dabei die gesetzeskonforme, sichere Meldung von Compliance-Verst\u00f6\u00dfen<\/span><span data-path-to-node=\"6,6\">.<\/span><\/p><h3 data-path-to-node=\"2\">Produktions-, Instandhaltungs- und Qualit\u00e4tsrisiken minimieren<\/h3><p data-path-to-node=\"3\"><span class=\"\" data-path-to-node=\"3,0\">Unvorhersehbare <b data-path-to-node=\"3,0\" data-index-in-node=\"16\">(9) Instandhaltungs- und Betriebsrisiken<\/b> (z. B. Ausfall von Reinraumanlagen) sowie <b data-path-to-node=\"3,0\" data-index-in-node=\"99\">(10) Qualit\u00e4ts- und GMP-Risiken<\/b> gef\u00e4hrden pharmazeutische Chargenprozesse<\/span><span class=\"\" data-path-to-node=\"3,2\">. OPTURE verkn\u00fcpft Validierungsmodelle direkt mit der Produktion<\/span><span class=\"\" data-path-to-node=\"3,4\">. Wartungszyklen und kritische Risikotreiber werden proaktiv berechnet, um kostspielige Stillst\u00e4nde und R\u00fcckrufe effektiv abzuwenden<\/span><span class=\"\" data-path-to-node=\"3,6\">.<\/span><\/p><h2 class=\"\" data-path-to-node=\"5\">Digitale Transformation und Cyber-Resilienz<\/h2><h3 class=\"\" data-path-to-node=\"6\">Schutz f\u00fcr Labor-IT, Produktionsanlagen und IoT (NIS2\/KRITIS)<\/h3><p data-path-to-node=\"7\"><span class=\"\" data-path-to-node=\"7,0\">Pharmazeutische Fertigungslinien und Labor-IT (LIMS) sind hochgradig vernetzt, was die Angriffsfl\u00e4che f\u00fcr Cyberattacken massiv vergr\u00f6\u00dfert<\/span><span data-path-to-node=\"7,2\">. Das <b data-path-to-node=\"7,2\" data-index-in-node=\"6\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/isms-cyber-security\/\">ISMS<\/a><\/b> stellt die Informationssicherheit vollautomatisch NIS2- und KRITIS-konform auf. Die Software identifiziert Schwachstellen in pharmazeutischen IT-Assets, steuert Schutzma\u00dfnahmen und sichert die gesetzliche Meldekette bei Cyber-Incidents.<\/span><\/p><h3 data-path-to-node=\"2\">Datensicherheit im Fokus: DSGVO-Sicherheit f\u00fcr klinische Studien und Patente<\/h3><p id=\"p-rc_ecdf04c19c96ddb7-76\" data-path-to-node=\"3\"><span data-path-to-node=\"3,0\">Ob hochsensible Patientendaten aus klinischen Phasen, gesch\u00fctzte Forschungsrezepturen oder Mitarbeiterkarteien \u2013 Pharmaunternehmen verwalten hochgradig regulierte Informationen<\/span><span data-path-to-node=\"3,2\">. Das intelligente Modul <b data-path-to-node=\"3,2\" data-index-in-node=\"25\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/datenschutzmanagement-system-dsms\/\">DSMS<\/a><\/b> digitalisiert das F\u00fchren von Verarbeitungsverzeichnissen (VVT), steuert systemische L\u00f6schkonzepte und sichert die l\u00fcckenlose Einhaltung aller Datenschutzvorgaben rechtssicher ab, um folgenschwere Sanktionen zu vermeiden<\/span><span data-path-to-node=\"3,4\">.<\/span><\/p><h2 data-path-to-node=\"5\">Pharma-Risikomanagement mit OPTURE RegOS<\/h2><h3 data-path-to-node=\"6\">Use Case 1: GMP-Compliance und Qualit\u00e4tsrisiken steuern<\/h3><p id=\"p-rc_ecdf04c19c96ddb7-77\" data-path-to-node=\"7\">Pharmaunternehmen m\u00fcssen GMP, GxP, FDA, EMA, AMWHV, Pharmakovigilanz und Validierungspflichten sicher erf\u00fcllen. Gleichzeitig k\u00f6nnen Qualit\u00e4tsabweichungen, Reinraumrisiken, Chargenfehler oder Anlagenst\u00f6rungen direkte Auswirkungen auf Produktion, Zulassung und Auditf\u00e4higkeit haben. <strong data-start=\"395\" data-end=\"411\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/regulatory-operating-system\/\">RegOS<\/a><\/strong> b\u00fcndelt Risiken, Ma\u00dfnahmen, Kontrollen und Nachweise in einer zentralen Plattform und unterst\u00fctzt eine transparente Pharma-Governance.<\/p><h3 data-path-to-node=\"2\">Use Case 2: F&amp;E und Lieferkettenrisiken absichern<\/h3><p id=\"p-rc_06d706a594a384ad-44\" data-path-to-node=\"3\">Klinische Studien, Entwicklungszyklen, Zulassungsverfahren, API-Abh\u00e4ngigkeiten und globale Produktionsnetzwerke erzeugen hohe Risiken f\u00fcr Pharmaunternehmen. Mit <strong data-start=\"768\" data-end=\"782\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/risikomanagement\/\">ERM<\/a><\/strong> werden F&amp;E-Risiken, Lieferkettenst\u00f6rungen, Qualit\u00e4tsrisiken und Produktionsvolatilit\u00e4t strukturiert bewertet. So entstehen belastbare Entscheidungsgrundlagen f\u00fcr Forschung, Produktion, Supply Chain und regulatorische Compliance.<\/p><blockquote data-path-to-node=\"31\"><p data-path-to-node=\"31,0\">\u201ePharmaunternehmen nutzen OPTURE <a href=\"https:\/\/opture.com\/loesungen\/regulatory-operating-system\/\">RegOS<\/a>, um GMP-Compliance, Qualit\u00e4tsrisiken, F&amp;E-Risiken und Lieferkettenrisiken zentral zu steuern, auditf\u00e4hig zu dokumentieren und regulatorische Anforderungen sicher zu erf\u00fcllen.\u201c<\/p><\/blockquote>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b5cd4aa e-flex e-con-boxed e-con e-parent\" data-id=\"b5cd4aa\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-ac04f15 e-con-full e-flex e-con e-child\" data-id=\"ac04f15\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6dc22d0 elementor-widget elementor-widget-heading\" data-id=\"6dc22d0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h6 class=\"elementor-heading-title elementor-size-default\">FAQ<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-df21f8a elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"df21f8a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Alles, was Sie \u00fcber die OPTURE L\u00f6sung f\u00fcr die Pharmaindustrie wissen m\u00fcssen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9253ac2 elementor-widget elementor-widget-button\" data-id=\"9253ac2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/opture.com\/contact-us\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Kontaktieren Sie uns<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a3b83e8 e-con-full e-flex e-con e-child\" data-id=\"a3b83e8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e3232c5 ui-e-animation-acc-basic ui-e-animation-ico-fade elementor-widget elementor-widget-uicore-accordion\" data-id=\"e3232c5\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;collapsible&quot;:&quot;true&quot;,&quot;active_hash&quot;:&quot;no&quot;,&quot;accordion_animation&quot;:&quot;ui-e-animation-acc-basic&quot;}\" data-widget_type=\"uicore-accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t        <div class=\"ui-e-accordion\" >\n\n                            <div class=\"ui-e-accordion-item ui-e-item\" role=\"button\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"ui-e-acc-1\" id=\"ui-e-wie-unterstuetzt-opture-die-steuerung-von-fe-risiken\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie unterst\u00fctzt OPTURE die Steuerung von F&amp;E-Risiken?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"display:none;\" aria-labelledby=\"ui-e-wie-unterstuetzt-opture-die-steuerung-von-fe-risiken\" id=\"ui-e-acc-1\">\n                        <p data-path-to-node=\"6\"><span data-path-to-node=\"5,0\">OPTURE <a href=\"https:\/\/opture.com\/loesungen\/risikomanagement\/\">ERM<\/a> Advanced nutzt simulationsbasierte Modelle, um Entwicklungszyklen, Portfolio-Risiken und die Erfolgswahrscheinlichkeiten klinischer Studien quantitativ und verl\u00e4sslich abzubilden<\/span><span data-path-to-node=\"5,2\">.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                            <div class=\"ui-e-accordion-item ui-e-item ui-open\" role=\"button\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"ui-e-acc-2\" id=\"ui-e-wie-hilft-opture-bei-gmp-und-regulatorischen-anforderungen\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie hilft OPTURE bei GMP- und regulatorischen Anforderungen?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"\" aria-labelledby=\"ui-e-wie-hilft-opture-bei-gmp-und-regulatorischen-anforderungen\" id=\"ui-e-acc-2\">\n                        <p data-path-to-node=\"7\"><span data-path-to-node=\"8,0\">Die Software gew\u00e4hrleistet strukturierte Dokumentationen, automatisierte Validierungs-Kontrollen und revisionssichere Nachweise f\u00fcr maximale Audit-Sicherheit bei Beh\u00f6rden<\/span><span data-path-to-node=\"8,2\">.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                            <div class=\"ui-e-accordion-item ui-e-item\" role=\"button\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"ui-e-acc-3\" id=\"ui-e-wie-integriert-sich-opture-in-labor-produktions-und-erp-systeme\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie integriert sich OPTURE in Labor-, Produktions- und ERP-Systeme?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"display:none;\" aria-labelledby=\"ui-e-wie-integriert-sich-opture-in-labor-produktions-und-erp-systeme\" id=\"ui-e-acc-3\">\n                        <p data-path-to-node=\"8\"><span data-path-to-node=\"11,0\">\u00dcber standardisierte Schnittstellen l\u00e4sst sich die Plattform nahtlos an Ihre bestehenden LIMS, MES, ERP, QMS, SCM und IoT-Infrastrukturen anbinden<\/span><span data-path-to-node=\"11,2\">.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                            <div class=\"ui-e-accordion-item ui-e-item\" role=\"button\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"ui-e-acc-4\" id=\"ui-e-wie-verbessert-opture-die-governance-in-globalen-lieferketten\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie verbessert OPTURE die Governance in globalen Lieferketten?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"display:none;\" aria-labelledby=\"ui-e-wie-verbessert-opture-die-governance-in-globalen-lieferketten\" id=\"ui-e-acc-4\">\n                        <p data-path-to-node=\"9\"><span data-path-to-node=\"14,0\">Die Plattform erm\u00f6glicht die zentrale, transparente Steuerung s\u00e4mtlicher API-Risiken, Ma\u00dfnahmen und Lieferabh\u00e4ngigkeiten \u00fcber alle Tier-1\/2\/3-Stufen hinweg<\/span><span data-path-to-node=\"14,2\">.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                            <div class=\"ui-e-accordion-item ui-e-item\" role=\"button\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"ui-e-acc-5\" id=\"ui-e-wie-unterstuetzt-opture-die-steuerung-von-qualitaetsrisiken\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie unterst\u00fctzt OPTURE die Steuerung von Qualit\u00e4tsrisiken?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"display:none;\" aria-labelledby=\"ui-e-wie-unterstuetzt-opture-die-steuerung-von-qualitaetsrisiken\" id=\"ui-e-acc-5\">\n                        <p data-path-to-node=\"10\"><span data-path-to-node=\"17,0\">Durch die gezielte \u00dcberwachung von Qualit\u00e4ts-KPIs, detaillierte Abweichungsanalysen und mathematische Validierungsmodelle wird die GMP-Qualit\u00e4t permanent gesichert<\/span><span data-path-to-node=\"17,2\">.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                            <div class=\"ui-e-accordion-item ui-e-item\" role=\"button\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"ui-e-acc-6\" id=\"ui-e-wie-schnell-laesst-sich-opture-implementieren\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie schnell l\u00e4sst sich OPTURE implementieren?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"display:none;\" aria-labelledby=\"ui-e-wie-schnell-laesst-sich-opture-implementieren\" id=\"ui-e-acc-6\">\n                        <p data-path-to-node=\"11\"><span data-path-to-node=\"20,0\">Die Einf\u00fchrung erfolgt dank branchenspezifischer Workflows in nur 6 bis 8 Wochen und ist jederzeit modular f\u00fcr <a href=\"https:\/\/opture.com\/loesungen\/risikomanagement\/\">Risiko<\/a>, <a href=\"https:\/\/opture.com\/loesungen\/esg\/\">ESG<\/a>, <a href=\"https:\/\/opture.com\/loesungen\/compliance-com\/\">Compliance<\/a>, <a href=\"https:\/\/opture.com\/loesungen\/internes-kontroll-system-iks\/\">IKS<\/a> und <a href=\"https:\/\/opture.com\/loesungen\/lieferkettengesetz-software\/\">Lieferantenmanagement<\/a> erweiterbar<\/span><span data-path-to-node=\"20,2\">.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                            <div class=\"ui-e-accordion-item ui-e-item\" role=\"button\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"ui-e-acc-7\" id=\"ui-e-wie-unterstuetzt-opture-isms-nis2-und-kritis-compliance\">\n\n                    <h4 class=\"ui-e-accordion-title ui-e-title ui-right\">\n\n                                                    <span class=\"ui-e-accordion-icon ui-e-icon ui-e-right\" aria-hidden=\"true\">\n\n                                <span class=\"ui-e-accordion-icon-closed\">\n                                    <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                <\/span>\n\n                                                                    <span class=\"ui-e-accordion-icon-opened\">\n                                        <svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg>                                    <\/span>\n                                \n                            <\/span>\n                        \n                                                <span class=\"ui-e-accordion-title-text ui-e-title-text\" >\n                                                        Wie unterst\u00fctzt OPTURE ISMS NIS2- und KRITIS-Compliance?                        <\/span>\n\n                    <\/h4>\n\n                    <div class=\"ui-e-accordion-content ui-e-content\" style=\"display:none;\" aria-labelledby=\"ui-e-wie-unterstuetzt-opture-isms-nis2-und-kritis-compliance\" id=\"ui-e-acc-7\">\n                        <p><span style=\"font-weight: 400\">Das OPTURE ISMS-Modul dokumentiert Sicherheitsvorkehrungen, deckt Schwachstellen auf und steuert Abwehrma\u00dfnahmen. So wird die digitale Resilienz vernetzter Prozessleitsysteme vollkommen NIS2- und KRITIS-konform organisiert.<\/span><\/p>                    <\/div>\n\n                <\/div>\n                    <\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Regulatorisches Risiko- und Compliance-Management f\u00fcr die Pharmaindustrie Mit der integrierten OPTURE RegOS Plattform steuern Pharmaunternehmen regulatorische Anforderungen, GMP-Qualit\u00e4tsprozesse, globale Lieferketten, komplexe Forschung [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":821,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1010","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharma Risikomanagement Software f\u00fcr GMP, GxP &amp; F&amp;E<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/opture.com\/fr\/branchen\/pharmaindustrie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Risikomanagement Software f\u00fcr GMP, GxP &amp; F&amp;E\" \/>\n<meta property=\"og:description\" content=\"Regulatorisches Risiko- und Compliance-Management f\u00fcr die Pharmaindustrie Mit der integrierten OPTURE RegOS Plattform steuern Pharmaunternehmen regulatorische Anforderungen, GMP-Qualit\u00e4tsprozesse, globale Lieferketten, komplexe Forschung [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/opture.com\/fr\/branchen\/pharmaindustrie\/\" \/>\n<meta property=\"og:site_name\" content=\"Opture\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-10T22:35:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/opture.com\\\/branchen\\\/pharmaindustrie\\\/\",\"url\":\"https:\\\/\\\/opture.com\\\/branchen\\\/pharmaindustrie\\\/\",\"name\":\"Pharma Risikomanagement Software f\u00fcr GMP, GxP & F&E\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/opture.com\\\/#website\"},\"datePublished\":\"2026-07-08T09:11:28+00:00\",\"dateModified\":\"2026-09-10T22:35:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/opture.com\\\/branchen\\\/pharmaindustrie\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/opture.com\\\/branchen\\\/pharmaindustrie\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/opture.com\\\/branchen\\\/pharmaindustrie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/opture.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Branchen\",\"item\":\"https:\\\/\\\/opture.com\\\/branchen\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pharmaindustrie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/opture.com\\\/#website\",\"url\":\"https:\\\/\\\/opture.com\\\/\",\"name\":\"Opture\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/opture.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Risikomanagement Software f\u00fcr GMP, GxP & F&E","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/opture.com\/fr\/branchen\/pharmaindustrie\/","og_locale":"fr_FR","og_type":"article","og_title":"Pharma Risikomanagement Software f\u00fcr GMP, GxP & F&E","og_description":"Regulatorisches Risiko- und Compliance-Management f\u00fcr die Pharmaindustrie Mit der integrierten OPTURE RegOS Plattform steuern Pharmaunternehmen regulatorische Anforderungen, GMP-Qualit\u00e4tsprozesse, globale Lieferketten, komplexe Forschung [&hellip;]","og_url":"https:\/\/opture.com\/fr\/branchen\/pharmaindustrie\/","og_site_name":"Opture","article_modified_time":"2026-09-10T22:35:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/opture.com\/branchen\/pharmaindustrie\/","url":"https:\/\/opture.com\/branchen\/pharmaindustrie\/","name":"Pharma Risikomanagement Software f\u00fcr GMP, GxP & F&E","isPartOf":{"@id":"https:\/\/opture.com\/#website"},"datePublished":"2026-07-08T09:11:28+00:00","dateModified":"2026-09-10T22:35:53+00:00","breadcrumb":{"@id":"https:\/\/opture.com\/branchen\/pharmaindustrie\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/opture.com\/branchen\/pharmaindustrie\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/opture.com\/branchen\/pharmaindustrie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/opture.com\/"},{"@type":"ListItem","position":2,"name":"Branchen","item":"https:\/\/opture.com\/branchen\/"},{"@type":"ListItem","position":3,"name":"Pharmaindustrie"}]},{"@type":"WebSite","@id":"https:\/\/opture.com\/#website","url":"https:\/\/opture.com\/","name":"Opture","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/opture.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/pages\/1010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/comments?post=1010"}],"version-history":[{"count":3,"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/pages\/1010\/revisions"}],"predecessor-version":[{"id":7037,"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/pages\/1010\/revisions\/7037"}],"up":[{"embeddable":true,"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/pages\/821"}],"wp:attachment":[{"href":"https:\/\/opture.com\/fr\/wp-json\/wp\/v2\/media?parent=1010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}